Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19.
- 2024-07-13
- RCT · n = 285
- European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 281(11)
- Mohamed H Abdelazim
- Faisal Alsenani
- Mohammed Alnuhait
- Abdullah S Alshammari
- Abdullah H Altemani
- Eyad A Althagafi
- Dania S Waggas
- Ahmed H Abdelazim
- Adnan Alharbi
- PubMed: 39001919
- DOI: 10.1007/s00405-024-08802-x
- High evidence
- Large Human Trial
- Clinical
Moreover, the discrimination and identification scores notably improved within the forskolin group.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes